Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FBE56
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,525
Award facts
- Contract value 100% obligated
- $25,525.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $25,525.08, awards AmerisourceBergen Drug Corp the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count) under a firm fixed price arrangement. The contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and represents a non-competitive delivery order issued by the Defense Logistics Agency (DLA). The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. Trelegy Ellipta is a combination inhaler medication used for chronic obstructive pulmonary disease management, reflecting the breadth of pharmaceutical products delivered through this contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FBE56?
SPE2DB25FBE56 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FBE56 worth?
The government has obligated $25,525 on SPE2DB25FBE56.
Is contract SPE2DB25FBE56 an order under another contract?
Yes. SPE2DB25FBE56 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB25FBE56 competed?
The extent of competition for SPE2DB25FBE56 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award